MX2022007086A - Agentes para la composicion oral. - Google Patents

Agentes para la composicion oral.

Info

Publication number
MX2022007086A
MX2022007086A MX2022007086A MX2022007086A MX2022007086A MX 2022007086 A MX2022007086 A MX 2022007086A MX 2022007086 A MX2022007086 A MX 2022007086A MX 2022007086 A MX2022007086 A MX 2022007086A MX 2022007086 A MX2022007086 A MX 2022007086A
Authority
MX
Mexico
Prior art keywords
foam
oral
agents
flavorant
lipid
Prior art date
Application number
MX2022007086A
Other languages
English (en)
Inventor
Anthony Richard Gerardi
Thomas H Poole
Christopher Keller
Ronald K Hutchens
Philip Richard Hunt
Original Assignee
Nicoventures Trading Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd
Priority claimed from PCT/IB2020/061546 external-priority patent/WO2021116865A1/en
Publication of MX2022007086A publication Critical patent/MX2022007086A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/38—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

La invención proporciona composiciones y productos configurados para uso oral. Por ejemplo, se proporciona una composición que incluye una espuma que contiene un lípido y un agente activo y/o un saborizante, y un vehículo, en donde la espuma es absorbida en el vehículo. Pudiéndose incorporar dicha espuma, por ejemplo, dentro de pastillas y/o productos orales en bolsas. La invención proporciona además un producto oral (por ejemplo, una pastilla y/o un producto oral en bolsa) que incluye un agente encapsulado, en donde el agente encapsulado es una perla porosa con una porción exterior y una porción interior que contiene un lípido y un agente activo y/o un saborizante.
MX2022007086A 2019-12-09 2020-12-04 Agentes para la composicion oral. MX2022007086A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962945640P 2019-12-09 2019-12-09
PCT/IB2020/061546 WO2021116865A1 (en) 2019-12-09 2020-12-04 Agents for oral composition

Publications (1)

Publication Number Publication Date
MX2022007086A true MX2022007086A (es) 2022-09-09

Family

ID=76209421

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022007086A MX2022007086A (es) 2019-12-09 2020-12-04 Agentes para la composicion oral.

Country Status (5)

Country Link
US (2) US20210169806A1 (es)
EP (1) EP4072338A1 (es)
JP (1) JP2023505351A (es)
CA (1) CA3159949A1 (es)
MX (1) MX2022007086A (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230148652A1 (en) 2021-11-15 2023-05-18 Nicoventures Trading Limited Oral products with nicotine-polymer complex
WO2023232332A2 (en) 2022-04-14 2023-12-07 Nicoventures Trading Limited Container for oral products
WO2023248187A1 (en) 2022-06-24 2023-12-28 Nicoventures Trading Limited Oral composition comprising a receptor modulator
US20240109697A1 (en) 2022-10-03 2024-04-04 Nicoventures Trading Limited Sealing member for packaging
WO2024074988A1 (en) 2022-10-04 2024-04-11 R. J. Reynolds Tobacco Company Stackable arrangement of product containers and related method of stacking
WO2024079696A1 (en) 2022-10-14 2024-04-18 Nicoventures Trading Limited Apparatus and method for manufacturing and inspecting a pouched product or at least one object associated therewith
WO2024079697A1 (en) 2022-10-14 2024-04-18 Nicoventures Trading Limited Apparatus and method for manufacturing a pouched product
WO2024079722A1 (en) 2022-10-14 2024-04-18 Nicoventures Trading Limited Capsule-containing pouched products
WO2024089588A1 (en) 2022-10-24 2024-05-02 Nicoventures Trading Limited Shaped pouched products
WO2024095164A1 (en) 2022-11-01 2024-05-10 Nicoventures Trading Limited Products with spherical filler
WO2024095162A1 (en) 2022-11-01 2024-05-10 Nicoventures Trading Limited Method of preparing a pouched product comprising a nicotine salt
WO2024095163A1 (en) * 2022-11-01 2024-05-10 Nicoventures Trading Limited Oral composition comprising encapsulated ph adjusting agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0415741B1 (pt) * 2003-11-07 2013-07-23 composições de tabaco e métodos de fabricação de uma composição de tabaco
CN102481257B (zh) * 2009-04-24 2014-08-13 Omya国际股份公司 用于控释活性成分的颗粒材料
US10881132B2 (en) * 2011-12-14 2021-01-05 R.J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition

Also Published As

Publication number Publication date
US20210330590A1 (en) 2021-10-28
JP2023505351A (ja) 2023-02-08
CA3159949A1 (en) 2021-06-17
US20210169806A1 (en) 2021-06-10
EP4072338A1 (en) 2022-10-19

Similar Documents

Publication Publication Date Title
MX2022007086A (es) Agentes para la composicion oral.
MX2022007021A (es) Un proceso para preparar un producto oral en bolsa y el producto obtenido a partir del mismo.
TR200202737T2 (tr) Aktif katkı maddeleri ihtiva eden şekerleme ürünleri.
MX349118B (es) Artículo para fumar con segmento de cambio de color.
MX2007009763A (es) Envase para un producto de cuidado personal.
MX2007012228A (es) Dispositivo para dosificar y para nebulizacion en seco.
WO2007056073A3 (en) Medical device with a coating comprising an active form and an inactive form of therapeutic agent(s)
WO2012075507A3 (en) Disinfectant spray with indicator
CA2890757C (en) Stable thermolysin hydrogel
IL287700A (en) Magnesium carbonate is surface backed as a carrier material for the release of one or more active ingredients in a home care formulation
AU2002239348A1 (en) Pyrazolopyridine derivatives
MX2022006905A (es) Productos en bolsa con estabilidad de sabor mejorada.
WO2013104892A8 (en) Application of high dose compounds via inhalation
EP3799747A4 (en) TOBACCO BASE FOR HEATING WITHOUT BURNING TO PREVENT THE FALLING OF TOBACCO AND ITS USE
MX2009011493A (es) Complejo de excipiente farmaceutico.
MY129564A (en) Compositions comprising cefuroxime axetil
MX2022006974A (es) Vellon para producto oral con componente liberable.
MX2022007090A (es) Producto oral con liberacion sostenida de sabor.
EP3875088A4 (en) Package for medical composition containing anti-tumor agent
MY185586A (en) Silica-based antimicrobial oral compositions
AU2017370226A1 (en) Pharmaceutical composition containing insulin-like growth factor-2 and use thereof
EP3790529B8 (en) Formulations containing active oxygen compounds and devices for application thereof
MX2019007633A (es) Composicion antitranspirante /desodorante.
MX2020003033A (es) Conjunto de envase y recipiente para el mismo, procedimiento de fabricacion de un conjunto de envase y procedimiento asociado de utilizacion y/o activacion de un agente activo.
DE60201074D1 (en) Pyrazolopyridinderivate